Morioka, Japan · Founded 2014 · Privately Held (backing)
Developer of in-vitro diagnostic agents and medical devices designed to offer the prognosis of endometriosis progression. Cellspect is based in Morioka, Japan and was founded in 2014. Its last reported valuation was $142 million in May 2019. It has raised $22.6 million.
Last reported valuation
$142.1M
Oct 2026
Priced at
—
Total raised
$22.6M
Last round
—
Team — not yet on record
No current team members for Cellspect are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cellspect with a free account
·The complete investor list: 15 names
·Watch Cellspect: the Monday email on marks, rounds and moves
